Quarterly Statement Of Cash Flows

PhoenixBio Co.,Ltd. - Filing #7598506

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-393,002,000 JPY
-160,891,000 JPY
-223,875,000 JPY
-262,032,000 JPY
Depreciation
86,238,000 JPY
55,442,000 JPY
Impairment losses
265,027,000 JPY
JPY
Interest expenses
952,000 JPY
1,167,000 JPY
Foreign exchange losses (gains)
-5,951,000 JPY
-6,117,000 JPY
Decrease (increase) in trade receivables
JPY
54,578,000 JPY
Decrease (increase) in inventories
-19,018,000 JPY
-56,489,000 JPY
Increase (decrease) in trade payables
-4,577,000 JPY
8,484,000 JPY
Other, net
8,323,000 JPY
-5,879,000 JPY
Subtotal
12,751,000 JPY
-128,656,000 JPY
Interest and dividends received
203,000 JPY
1,058,000 JPY
Interest paid
-955,000 JPY
-973,000 JPY
Income taxes paid
-4,175,000 JPY
-2,726,000 JPY
Net cash provided by (used in) operating activities
16,398,000 JPY
-101,909,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-6,771,000 JPY
-181,020,000 JPY
Other, net
-203,000 JPY
-2,458,000 JPY
Net cash provided by (used in) investing activities
-6,975,000 JPY
-184,775,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-2,481,000 JPY
-20,004,000 JPY
Net cash provided by (used in) financing activities
-34,658,000 JPY
-160,194,000 JPY
Effect of exchange rate change on cash and cash equivalents
22,930,000 JPY
-737,000 JPY
Net increase (decrease) in cash and cash equivalents
-2,305,000 JPY
-447,616,000 JPY
Cash and cash equivalents
1,325,507,000 JPY
1,327,813,000 JPY
1,775,429,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.